These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 27348728)
1. Protective potential of epigallocatechin-3-gallate against benign prostatic hyperplasia in metabolic syndrome rats. Chen J; Song H Environ Toxicol Pharmacol; 2016 Jul; 45():315-20. PubMed ID: 27348728 [TBL] [Abstract][Full Text] [Related]
2. Epigallocatechin-3-gallate attenuates lipopolysaccharide-induced mastitis in rats via suppressing MAPK mediated inflammatory responses and oxidative stress. Chen J; Xu J; Li J; Du L; Chen T; Liu P; Peng S; Wang M; Song H Int Immunopharmacol; 2015 May; 26(1):147-52. PubMed ID: 25840281 [TBL] [Abstract][Full Text] [Related]
4. Paraventricular Nucleus Infusion of Epigallocatechin-3-O-Gallate Improves Renovascular Hypertension. Yi QY; Qi J; Yu XJ; Li HB; Zhang Y; Su Q; Shi T; Zhang DM; Guo J; Feng ZP; Wang ML; Zhu GQ; Liu JJ; Shi XL; Kang YM Cardiovasc Toxicol; 2016 Jul; 16(3):276-85. PubMed ID: 26162770 [TBL] [Abstract][Full Text] [Related]
5. Green tea, black tea, and epigallocatechin modify body composition, improve glucose tolerance, and differentially alter metabolic gene expression in rats fed a high-fat diet. Chen N; Bezzina R; Hinch E; Lewandowski PA; Cameron-Smith D; Mathai ML; Jois M; Sinclair AJ; Begg DP; Wark JD; Weisinger HS; Weisinger RS Nutr Res; 2009 Nov; 29(11):784-93. PubMed ID: 19932867 [TBL] [Abstract][Full Text] [Related]
6. The anti-hyperplasia, anti-oxidative and anti-inflammatory properties of Qing Ye Dan and swertiamarin in testosterone-induced benign prostatic hyperplasia in rats. Wu X; Gu Y; Li L Toxicol Lett; 2017 Jan; 265():9-16. PubMed ID: 27866977 [TBL] [Abstract][Full Text] [Related]
8. Green tea catechins decrease oxidative stress in surgical menopause-induced overactive bladder in a rat model. Juan YS; Chuang SM; Lee YL; Long CY; Wu TH; Chang WC; Levin RM; Liu KM; Huang CH BJU Int; 2012 Sep; 110(6 Pt B):E236-44. PubMed ID: 22639915 [TBL] [Abstract][Full Text] [Related]
9. Protective effect of epigallocatechin gallate, a major constituent of green tea, against renal ischemia-reperfusion injury in rats. Lv J; Feng M; Zhang L; Wan X; Zeng YC; Liang PF; Xu AP Int Urol Nephrol; 2015 Aug; 47(8):1429-35. PubMed ID: 26122117 [TBL] [Abstract][Full Text] [Related]
10. Epigallocatechin gallate attenuates experimental non-alcoholic steatohepatitis induced by high fat diet. Kuzu N; Bahcecioglu IH; Dagli AF; Ozercan IH; Ustündag B; Sahin K J Gastroenterol Hepatol; 2008 Aug; 23(8 Pt 2):e465-70. PubMed ID: 17683497 [TBL] [Abstract][Full Text] [Related]
11. Paljung-San, a traditional herbal medicine, attenuates benign prostatic hyperplasia in vitro and in vivo. Park E; Lee MY; Jeon WY; Seo CS; You S; Shin HK J Ethnopharmacol; 2018 May; 218():109-115. PubMed ID: 29501675 [TBL] [Abstract][Full Text] [Related]
12. Novel chemotherapeutic and renal protective effects for the green tea (EGCG): role of oxidative stress and inflammatory-cytokine signaling. El-Mowafy AM; Al-Gayyar MM; Salem HA; El-Mesery ME; Darweish MM Phytomedicine; 2010 Dec; 17(14):1067-75. PubMed ID: 20851589 [TBL] [Abstract][Full Text] [Related]
14. Epigallocatechin gallate improves serum lipid profile and erythrocyte and cardiac tissue antioxidant parameters in Wistar rats fed an atherogenic diet. Ramesh E; Elanchezhian R; Sakthivel M; Jayakumar T; Senthil Kumar RS; Geraldine P; Thomas PA Fundam Clin Pharmacol; 2008 Jun; 22(3):275-84. PubMed ID: 18485145 [TBL] [Abstract][Full Text] [Related]
15. The effect of orally administered epigallocatechin-3-gallate on ligature-induced periodontitis in rats. Cho AR; Kim JH; Lee DE; Lee JS; Jung UW; Bak EJ; Yoo YJ; Chung WG; Choi SH J Periodontal Res; 2013 Dec; 48(6):781-9. PubMed ID: 23581513 [TBL] [Abstract][Full Text] [Related]
16. Epigallocatechin gallate prevents inflammation by reducing macrophage infiltration and inhibiting tumor necrosis factor-α signaling in the pancreas of rats on a high-fat diet. Cao Y; Bao S; Yang W; Zhang J; Li L; Shan Z; Teng W Nutr Res; 2014 Dec; 34(12):1066-74. PubMed ID: 25453543 [TBL] [Abstract][Full Text] [Related]
17. Effects of dietary supplementation with epigallocatechin-3-gallate on weight loss, energy homeostasis, cardiometabolic risk factors and liver function in obese women: randomised, double-blind, placebo-controlled clinical trial. Mielgo-Ayuso J; Barrenechea L; Alcorta P; Larrarte E; Margareto J; Labayen I Br J Nutr; 2014 Apr; 111(7):1263-71. PubMed ID: 24299662 [TBL] [Abstract][Full Text] [Related]
18. Epigallocatechin-3-gallate reduces the proliferation of benign prostatic hyperplasia cells via regulation of focal adhesions. Tepedelen BE; Soya E; Korkmaz M Life Sci; 2017 Dec; 191():74-81. PubMed ID: 29032114 [TBL] [Abstract][Full Text] [Related]